Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States

Karynsa Cetin, Leah J McGrath, PhD, Robert Overman, PhD, Diane Reams, Pharm.D., MPH, Anjali Sharma, MD, M. Alan Brookhart, PhD, Ivy Altomare, MD, Jeffrey S. Wasser, MD

Blood (2018) 132 (Supplement 1): 497.

https://doi.org/10.1182/blood-2018-99-117252

Published: 2018

Journal Articles

Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data

Shuling Li, PhD, Julia T Molony, MS, Karynsa Cetin, MPH, Jeffrey S Wasser, MD, Ivy Altomare, MD

Blood (2015) 126 (23): 38.

https://doi.org/10.1182/blood.V126.23.38.38

Published: 2015

Journal Articles

BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL

Yueming Chang, MD PhD, Jeffrey S Wasser, MD, Adam Boruchov, MD, Bruce J Mayer, PhD, Kazuya Machida, MDPhD

Blood (2015) 126 (23): 4128.

https://doi.org/10.1182/blood.V126.23.4128.4128

Published: 2015

Journal Articles

Cost of Bleeding-Related Episodes (BREs) in Adult Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States

Junji Lin, PhD, Xinke Zhang, MS, Xiaoyan Li, PhD, Ivy Altomare, MD, Jeffrey S Wasser, MD, Karynsa Cetin, MPH

Blood (2015) 126 (23): 3274.

https://doi.org/10.1182/blood.V126.23.3274.3274

Published: 2015

Journal Articles

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, Roger M Lyons, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun

Blood (2010) 116 (21): 68.

https://doi.org/10.1182/blood.V116.21.68.68

Published: 2010

NARROW

Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States

Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data

BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL

Cost of Bleeding-Related Episodes (BREs) in Adult Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

Email alerts

ASH Publications

American Society of Hematology

Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States

Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data

BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL

Cost of Bleeding-Related Episodes (BREs) in Adult Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only